The Global Electrical Ablation Market, mainly driven by increasing aging population with high risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $867 million in 2013 and is expected to reach $1098 million by 2018. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011.
Tachycardia, Atrial Arrhythmia conditions occur in people where cardiac electrical impulses move abnormally through a deviated path involving extra tissue and this impulse creates an abnormal pattern of elevated or decreased heart-beats in a patient. Electrical ablation is used for such conditions and involves ablating healthy cells so as to cut off electrical impulses transmitted that cause uneven heart beats. The procedure can be done percutaneously or by minimally invasive technique using ultrasound imaging, fluoroscopy and MRI.
The report “Electrical Ablation Market forecast, 2010-2018” analyzes the market of devices - Electrical Ablators and Electronic Brachytherapy. The high (above 70%) success rate for removal of arrhythmic heart conditions is the major factor that is driving this market. There are over 14 million arrhythmia cases with fatality of 15% annually. Globally, it affects over 10% of population over the age of 80. This rate of increase in heart conditions is predicted to sustain the electrical ablation technology market through 2016, by the low CAGR of just 5.2%.
Due to huge obese population (~30% of U.S. population) and high diabetic patient pool, it is expected that incidences of cardiovascular related disorders will continue to grow in the future. As established market players consider cancer and cardiovascular diseases, as the top application and majorly focused areas, Americas will continue to be a big market for ablation devices and will continue to offer opportunities in future. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for electrical ablation devices.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive ablation devices is emerging as an important factor. It has provided an opportunity for ablation devices companies, to have an established and growing market in these countries.
European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Aging Japanese population, which is at a higher risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately lead to growth in procedure volume of electrical ablation devices market in the future.
Traditional electrical ablation probes are not effective for ablating certain tissue types such as adhesions which develop in a large fraction of patients after surgery. Thus, there is an unmet need for devices that are suitable for ablating a variety of abnormal tissues, adhesions, and fibrous growths. Minimally invasive surgical devices are yet another area of expansion for market players in the ablation technologies market.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in electrical ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
The market data enables you can to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
List Of Figures
1 Electrical Ablation Ecosystem
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Americas Electrical Ablation
The American Electrical Ablation Market was pegged at $387 million in 2013 and expected to be $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Asia-Pacific Electrical Ablation
The Asia-Pacific electrical ablation market was valued at $159.0 million in 2013 and is expected to reach $236.0 million by 2018. In the electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in Asia-Pacific Electrical Ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
European Electrical Ablation
The European electrical ablation market was valued at $189.0 million in 2013 and is expected to reach $228.0 million by 2018. In the European electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).